Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Robert Kelly,
This session, proposed by the Council on Basic Cardiovascular Science, focused on exciting new mechanistic insights into the etiology of congenital heart defects (CHD), that affect 1% of live births. Regulators of chromatin structure, that control transcription factor accessibility during gene expression and have recently been identified in a de novo mutation screen to be a major contributor to CHD, were the subject of the first two talks.
Antonio Baldini (Naples) showed how components of the chromatin remodeling complex switch during early cardiac differentiation and how progenitor cell-specific subunits are essential for activity of the transcription factor TBX1, encoded by the major 22q11.2 deletion or DiGeorge syndrome gene. 22q11.2 deletion syndrome patients have a spectrum of CHD, including common outflow tract defects such as tetralogy of Fallot, and TBX1 also interacts with histone methyltransferase enzymes to modulate cis-regulatory sequence accessibility during cardiac differentiation.
Chromatin regulation is also a critical control step in gene expression changes during hypertrophy and heart failure as shown by the second speaker, Sarah Franklin (Salt Lake City). Here we learnt how changes in expression of histone methyl transferase genes modulate the hypertrophic response by repressing fetal gene re-expression.
The final talk of the session brought us back to the early heart, but away from chromatin, focusing on the addition of cardiac progenitor cells to the elongating heart tube. Here the planar cell polarity pathway, that orients cells within an epithelium, is essential for normal heart tube extension and great artery alignment with the ventricular chambers. Deborah Henderson (Newcastle) showed how planar cell polarity is required in cardiac progenitor cells for normal outflow tract morphogenesis, site of 40% of CHD. These exciting findings point to progenitor cell polarity as a being a major research focus in the etiology of common forms of CHD.
Novel biology of congenital heart defects
© 2016 European Society of Cardiology. All rights reserved